Avalide Tablet, Film Coated
Product Images NDC 0024-5855

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Avalide (NDC 0024-5855). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1a (Avalide 01)

FDA Label Image

Figure 1b (Avalide 02)

This data may represent blood pressure readings taken with a monitoring device named Baseliro SBP (measured in mmHg). However, without further context or additional data, it is not possible to provide a more specific description.*

FDA Label Image

Figure 2a (Avalide 03)

FDA Label Image

Figure 2b (Avalide 04)

FDA Label Image

Chemical Structure (Avalide 05)

FDA Label Image

Chemical Structure (Avalide 06)

FDA Label Image

Figure 3 (Avalide 07)

FDA Label Image

Figure 4 (Avalide 08)

FDA Label Image

Principal Display Panel (150/12.5 mg Tablet Bottle Label)

This is a description of a drug package called "Avalide" which contains 30 tablets, each containing 150/12.5 mg of irbesartan-hydrochlorothiazide. The drug is manufactured by Sanofi and the package has the NDC code 0024-5855-30. The package insert or dosing information should be read before consumption. The drug should be stored at temperatures between 10-15°C to 30°C (between 59°F to 86°F). The package also contains the trademark symbol for "Avalide." The origin of the package is France.*

FDA Label Image

Principal Display Panel (300/12.5 mg Tablet Bottle Label)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.